Auwerx, J., Stevens, M., Van Rompay, A., Bird, L., Ren, J., De Clercq, E., . . . Balzarini, J. (2004). The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.
Chicago-referens (17:e uppl.)Auwerx, J., et al. The Phenylmethylthiazolylthiourea Nonnucleoside Reverse Transcriptase (RT) Inhibitor MSK-076 Selects for a Resistance Mutation in the Active Site of Human Immunodeficiency Virus Type 2 RT. 2004.
MLA-referens (9:e uppl.)Auwerx, J., et al. The Phenylmethylthiazolylthiourea Nonnucleoside Reverse Transcriptase (RT) Inhibitor MSK-076 Selects for a Resistance Mutation in the Active Site of Human Immunodeficiency Virus Type 2 RT. 2004.